Skip to main content
Clinical Trials/JPRN-C000000402
JPRN-C000000402
Completed
未知

A randomized, controlled study comparing the efficacy of peginterferon alfa-2b plus standard or reduced dose ribavirin in serotype 2 chronic hepatitis C - Shonan-Tokai Interferon Research for Serogroup 2 (STIRS2)

Tokai University School of Medicine0 sites120 target enrollmentStarted: April 17, 2006Last updated:

Overview

Phase
未知
Status
Completed
Enrollment
120

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) pregnant women (2\) patients allergic to ribavirin or IFN (3\) patients with uncontrolled heart diseases (4\) patients with abnormal hemoglobin (5\) patients with chronic renal diseases (6\) patients with severe depression or mental illness (7\) patinets with liver cirrhosis or liver failure (8\) patients who can not discontinue other antiviral or immunomodulating drugs

Investigators

Similar Trials